藥物濫用-可樂含有添加劑檢測試紙
| 型 號(hào)： | |
| 報(bào) 價(jià)： |  |
藥物濫用-可樂含有添加劑檢測試紙：在很多食物中都含有食品添加劑，而其中有一些是會(huì)危害到身體健康的?，F(xiàn)在有一種快速檢測出食品中是否含有添加劑或者添加劑過量的檢測試劑，準(zhǔn)確率高，速度快。
- 產(chǎn)品描述
藥物濫用-可樂含有添加劑檢測試紙
廣州健侖生物科技有限公司
The OPI One Step Opiate Test Device is an immunoassay based on the principle of competitive binding. Drugs which may be present in the urine specimen compete against the drug conjugate for binding sites on the antibody.
During testing, a urine specimen migrates upward by capillary action. Morphine, if present in the urine specimen below 2000 ng/mL, will not saturate the binding sites of the antibody in the test device. The Morphine conjugate will be captured by antibody and a visible colored line will show up in the test line region. The colored line will not form in the test line region if the Morphine level exceeds 2000 ng/mL because it will saturate all the binding sites of anti-Morphine antibodies.
A drug-positive urine specimen will not generate a colored line in the test line region because of drug competition, while a drug-negative urine specimen will generate a line in the test line region because of the absence of drug competition.
To serve as a procedural control, a colored line will always appear at the control line region, indicating that proper volume of specimen has been added and
藥物濫用-可樂含有添加劑檢測試紙
產(chǎn)品特點(diǎn)
1．準(zhǔn)確 參照藥物濫用監(jiān)測標(biāo)準(zhǔn)，設(shè)計(jì)了符合國內(nèi)情況的檢測閾值；
2．特異 選用高特異性的單克隆抗體，將可能發(fā)生的交叉反應(yīng)降到zui低程度；
3．快捷 尿液滴入5分鐘后，肉眼即可判讀結(jié)果；
4．穩(wěn)定 美國納米金高科技成果，質(zhì)量比其他同類產(chǎn)品更穩(wěn)定可靠；
5．方便不許任何設(shè)備及附加檢測，操作簡單。
Multi DOA Screen Panel are rapid chromatographic immunoassays for the qualitative and simultaneous detection of one to fourteen of the following drugs in a variety of combinations in human urine. The designed cutoff concentrations and direct calibrator for these drugs are as follows:
Parameter | Calibrator | Cut-off(ng/mL) |
THC | 11-nor-D9-THC-9-COOH | 50 ng/ml |
COC | Benzoylecgonine | 300 ng/ml |
PCP | Phencyclidine | 25 ng/ml |
OPI | Morphine | 2000 ng/ml |
MET | Methamphetamine | 1000 ng/ml |
MTD | Methadone | 300 ng/ml |
AMP | Amphetamine | 1000 ng/ml |
BAR | Secobarbital | 300 ng/ml |
BZO | Oxazepam | 300 ng/ml |
TCA | Nortriptyline | 1000 ng/ml |
MDMA | 3,4-Methylenediioxy-MET | 500 ng/ml |
BUP | BUP-3-D-Glucuronide | 10 ng/ml |
EDDP | EDDP | 100 ng/ml |
OPI/MOR | Morphine | 300 ng/ml |
KET | Ketamine | 1,000ng/ml |
TML | Cis-Tramadol | 100ng/ml |
OXY | Oxycodone | 100ng/ml |
PPX | Propoxyphene | 300ng/ml |
K2 | JWH-073/JWH-01 | 50 ng/ml |
FYL | * | 200 ng/ml |
COT | Cotinine | 200 ng/ml |
ALC | Alcohol |
|
獨(dú)立包裝：BZO-BAR-COC--THC -MET--OPI-OXY-MDMA-PCP- AMP-XTC-MTD 或聯(lián)檢
添加掃一掃二維碼：
【公司名稱】 廣州健侖生物科技有限公司
【市場部】 楊永漢
【】
【騰訊 】
【公司地址】 廣州市清華科技園健新基地番禺石樓鎮(zhèn)健啟路63號(hào)二期2幢101-103室
企業(yè)文化
